Dmitry Balyasny’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$82.6K Buy
+18,603
New +$83.4K ﹤0.01% 2913
2025
Q2
– Sell
-66,748
Closed -$560K – 3349
2025
Q1
$560K Buy
66,748
+55,025
+469% +$495K ﹤0.01% 2235
2024
Q4
$87.2K Sell
11,723
-189,380
-94% -$1.27M ﹤0.01% 2614
2024
Q3
$1.17M Buy
+201,103
New +$1.29M ﹤0.01% 1900
2024
Q2
– Sell
-28,319
Closed -$370K – 3109
2024
Q1
$370K Buy
28,319
+17,452
+161% +$233K ﹤0.01% 2179
2023
Q4
$139K Buy
+10,867
New +$110K ﹤0.01% 2358
2022
Q2
– Sell
-20,109
Closed -$380K – 3181
2022
Q1
$380K Buy
+20,109
New +$391K ﹤0.01% 1871

Other funds holding TMCI

Dmitry Balyasny's TMCI Position: Q3 2026 in Review

Dmitry Balyasny opened a new position in Treace Medical Concepts (TMCI) in Q3 2026: 18,603 shares worth $82.6K. The stake represents ﹤0.01% of the portfolio and ranks #2913 among its holdings. This is a return to the name: Dmitry Balyasny previously reported a position in TMCI as recently as Q1 2025.

Dmitry Balyasny first reported a position in TMCI in Q1 2022 and has held it in 7 quarters since. The position peaked at $1.17M in Q3 2024. 116 funds tracked by Wall St. Rank hold TMCI as of Q3 2026.

  • Dmitry Balyasny held 18,603 shares of Treace Medical Concepts worth $82.6K as of Q3 2026.
  • Treace Medical Concepts was a new Dmitry Balyasny position in Q3 2026.
  • Treace Medical Concepts made up ﹤0.01% of Dmitry Balyasny's portfolio in Q3 2026, its #2913 holding.
  • Dmitry Balyasny first reported a position in Treace Medical Concepts in Q1 2022 and has held it in 7 quarters since.
  • Dmitry Balyasny's Treace Medical Concepts position peaked at $1.17M in Q3 2024.
  • 116 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q3 2026.

Based on Balyasny Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.